Conclusion A new drug named tirzepatide has been approved to treat T2DM, and it is expected to be approved for weight loss by activating both GLP-1 and GIP receptors through a unique mechanism
Retrieved from Dahl, D., Onishi, Y., Norwood, P., et al
The provider will then determine if you are eligible for weight-loss medication and provide a personalized weight-loss plan for you
Safety And Medical Review Talk with your prescriber about goals, side effects, and medical history before switching or combining treatments
Provider Oversight Treatment is based on medical evaluation and provider approval
Thats why your journey starts with a comprehensive consultation to determine the best option for your unique body, goals, and lifestyle